Name | Milford Center |
---|---|
Location | 700 Marvel Road, Milford, Delaware |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 136 |
Occupancy Rate | 77.5% |
Medicare ID (CCN) | 085010 |
Legal Business Name | 700 Marvel Road Operations Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1619919990 |
Organization Name | GENESIS PROPERTIES OF DELAWARE LTD |
Doing Business As | MILFORD CENTER |
Address | 700 Marvel Rd, Milford, DE 19963 |
Phone Number | 302-422-3303 |
News Archive
MUSC Hollings Cancer Center researchers identified that blocking an alternative energy pathway for T-cells after hematopoietic stem cell transplant helps reduce graft-versus-host disease (GVHD) in an animal model of leukemia.
Sirtris Pharmaceuticals has announced that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including Type 2 Diabetes, by targeting SIRT1, a gene that controls the aging process.
Victoria's hospitals have performed poorly on their report cards that judged them against statewide benchmarks for emergency care and elective surgery. In some areas, the performance has worsened.
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.
› Verified 3 days ago
NPI Number | 1790967446 |
Organization Name | 700 MARVEL ROAD OPERATIONS LLC |
Doing Business As | MILFORD CENTER |
Address | 700 Marvel Rd, Milford, DE 19963 |
Phone Number | 302-422-3303 |
News Archive
MUSC Hollings Cancer Center researchers identified that blocking an alternative energy pathway for T-cells after hematopoietic stem cell transplant helps reduce graft-versus-host disease (GVHD) in an animal model of leukemia.
Sirtris Pharmaceuticals has announced that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including Type 2 Diabetes, by targeting SIRT1, a gene that controls the aging process.
Victoria's hospitals have performed poorly on their report cards that judged them against statewide benchmarks for emergency care and elective surgery. In some areas, the performance has worsened.
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
MUSC Hollings Cancer Center researchers identified that blocking an alternative energy pathway for T-cells after hematopoietic stem cell transplant helps reduce graft-versus-host disease (GVHD) in an animal model of leukemia.
Sirtris Pharmaceuticals has announced that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including Type 2 Diabetes, by targeting SIRT1, a gene that controls the aging process.
Victoria's hospitals have performed poorly on their report cards that judged them against statewide benchmarks for emergency care and elective surgery. In some areas, the performance has worsened.
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 2 |
Total Amount of Fines in Dollars | $23525 |
Number of Payment Denials | 0 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 21.79 | 14.46 |
Percentage of long-stay residents who lose too much weight | 11.28 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 53.33 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.35 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 5.32 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 10.82 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 6.05 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 90.76 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 15.18 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 73.57 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.17 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 42.12 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.24 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 12.62 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.56 | 95.98 |
Percentage of short-stay residents who made improvements in function | 62.56 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 80.64 | 82.93 |
News Archive
MUSC Hollings Cancer Center researchers identified that blocking an alternative energy pathway for T-cells after hematopoietic stem cell transplant helps reduce graft-versus-host disease (GVHD) in an animal model of leukemia.
Sirtris Pharmaceuticals has announced that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including Type 2 Diabetes, by targeting SIRT1, a gene that controls the aging process.
Victoria's hospitals have performed poorly on their report cards that judged them against statewide benchmarks for emergency care and elective surgery. In some areas, the performance has worsened.
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.
› Verified 3 days ago
Delaware Veterans Home Location: 100 Delaware Veterans Blvd, Milford, Delaware 19963 Phone: (302) 424-6000 | |
Polaris Healthcare And Rehabilitation Center Location: 21 W Clarke Avenue, Milford, Delaware 19963 Phone: (302) 503-7650 |